Radiolabeled FAP-targeting small ligands based on FAP inhibitors (FAPI) have recently been introduced and demonstrated very promising characteristics for PET imaging such as high and fast uptake in a variety of cancers and rapid clearance from the majority of healthy organs [4–6]. Here, FAP is linked to cancer.